BioCentury
ARTICLE | Company News

Fate Therapeutics management update

May 19, 2008 7:00 AM UTC

Fate Therapeutics, Seattle, Wash. Business: Cancer, Musculoskeletal, Gene/Cell therapy Hired: Paul Grayson as president and CEO, formerly a managing director at Sanderling Ventures; he succeeds Presid...